Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|124|4|743-751

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.4, 2018-02, pp. : 743-751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 84, Iss. 2, 2012-11 ,pp. : 108-114

Karger

Access to resources Recommend Favorite

Treatment of Hepatocellular Carcinoma

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 43-49

Karger

Access to resources Recommend Favorite

Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 98-103

Karger

Access to resources Recommend Favorite

Multimodal treatment of unresectable hepatocellular carcinoma to achieve complete response results in improved survival

By  

HPB, Vol. 17, Iss. 5, 2015-05 ,pp. : 454-460

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 12, 2015-12 ,pp. : 1156-1163

John Wiley & Sons Inc

Access to resources Recommend Favorite